PBX3在多发性骨髓瘤患者中的表达及与预后的关系  

Expression of PBX3 in patients with multiple myeloma and its relationship with prognosis

作　　者：杨建英 陆光兵 李汶航 文彬 YANG Jianying;LU Guangbing;LI Wenhang;WEN Bin(Department of Oncology and Hematology,Traditional Chinese Medicine Hospital of Meishan,Meishan 620000,China;Department of Internal Medicine,Traditional Chinese Medicine Hospital of Meishan,Meishan 620000,China;Department of Nephrology,Traditional Chinese Medicine Hospital of Meishan,Meishan 620000,China)

机构地区：[1]眉山市中医医院肿瘤血液科,四川眉山620000 [2]眉山市中医医院内科,四川眉山620000 [3]眉山市中医医院肾脏内科,四川眉山620000

出　　处：《现代医学》2024年第12期1936-1941,共6页Modern Medical Journal

摘　　要：目的:探讨B细胞白血病同源盒基因3(PBX3)在多发性骨髓瘤(MM)患者骨髓中的表达及与预后的关系。方法:选择2018年1月至2020年7月间我院收治的106例MM患者为研究对象。免疫组化法检测骨髓中PBX3表达,根据MM患者骨髓中PBX3表达情况分为PBX3阳性组(n=76)和PBX3阴性组(n=30)。其中4例患者随访中失访。根据MM患者3年预后分为存活组(n=63)和死亡组(n=39)。MM患者预后的影响因素采用多因素Cox回归分析;Kaplan-Meier法绘制MM患者不同PBX3表达的生存曲线。结果:与PBX3阴性组比较,PBX3阳性组DSⅢ期、国际分期系统(ISS)Ⅲ期、乳酸脱氢酶(LDH)≥245 U·L^(-1)及血小板计数(PLT)<100×10^(9)L^(-1)的占比较高(P<0.05)。多因素Cox回归分析显示,DS分期、ISS分期、危险分层、β2-微球蛋白(β2M)和PBX3表达均为MM患者预后的影响因素(P<0.05)。PBX3阳性组的3年总存活率(50.00%)低于PBX3阴性组(83.33%)(P<0.05)。结论:MM患者骨髓中PBX3阳性表达率较高,且PBX3表达与患者临床病理特征及预后密切相关。Objective:To investigate the expression of pre-B-cell leukemia homeobox 3(PBX3)in the bone marrow of patients with multiple myeloma(MM)and its relationship with prognosis.Methods:From January 2018 to July 2020,106 MM patients admitted to our hospital were selected as the study objects.The expression of PBX3 in bone marrow was detected by immunohistochemistry.Based on the expression of PBX3 in the bone marrow,patients were divided into PBX3 postive group(n=76)and PBX3 negative group(n=30).4 patients were lost to follow-up during the follow-up visits.Complying with the 3-year prognosis,MM patients were divided into survival group(n=63)and death group(n=39).The influencing factors of prognosis in MM patients were analyzed by Cox regression analysis.Kaplan-Meier method was used to plot the survival curves of MM patients with different PBX3 expression.Results:Compared with PBX3 negative group,the proportions of Durie-Salmon(DS)stage III,international staging system(ISS)stage III,lactate dehydrogenase(LDH)≥245 U·L^(-1)and platelet count(PLT)<100×10^(9)L^(-1)were higher in PBX3 positive group(P<0.05).Multivariate Cox regression analysis showed that DS stage,ISS stage,risk stratification,β2-microglobulin(β2M),and PBX3 were all influencing factors for the prognosis of MM patients(P<0.05).The 3-year overall survival rate of PBX3 positive group(50.00%)was lower than that of PBX3 negative group(83.33%)(P<0.05).Conclusion:The positive expression rate of PBX3 in the bone marrow of MM patients is relatively high,and the expression of PBX3 is closely related to the clinical pathological features and prognosis.

关 键 词：多发性骨髓瘤 B细胞白血病同源盒基因3 预后 相关性 

分 类 号：R733.3[医药卫生—肿瘤]